Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Accelerate Diagnostics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Accelerate Diagnostics

Accelerate Diagnostics

Public

Diagnostics firm offering automated antibiotic susceptibility results from blood cultures via Accelerate Pheno™ System.

HQ
Tucson, AZ, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Accelerate Diagnostics is a diagnostics firm dedicated to improving patient outcomes and combating antimicrobial resistance through innovative technology. Their core product, the Accelerate Pheno™ System, provides fully automated antibiotic susceptibility results directly from positive blood cultures. This system aids healthcare providers in making timely and accurate treatment decisions for patients with serious infections. The company focuses on clinical microbiology, addressing challenges in rapid diagnostics and effective treatment.

Accelerate Diagnostics has made significant strides in the field of clinical microbiology, with numerous publications and patient case studies highlighting their impact. Their collaboration with BD aims to enhance patient care and slow the spread of antimicrobial resistance. The company offers comprehensive support, including technical assistance and product orders, ensuring seamless integration of their solutions in healthcare settings.

Accelerate Diagnostics - Quick Facts

When was Accelerate Diagnostics founded?

Accelerate Diagnostics was founded in 2004.

Where is Accelerate Diagnostics' headquarters located?

Accelerate Diagnostics' headquarters is located in Tucson, AZ, US.

When was Accelerate Diagnostics' last funding round?

Accelerate Diagnostics' most recent funding round was for $15M (USD) in January 2024.

How much has Accelerate Diagnostics raised to-date?

As of Jan 19, 2024, Accelerate Diagnostics has raised a total of $264.1M (USD).

How many employees does Accelerate Diagnostics have?

Accelerate Diagnostics has 179 employees as of Feb 6, 2024.

Accelerate Diagnostics - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Automation
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Medical Devices
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment
Show 33 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 334600Manufacturing and Reproducing Magnetic and Optical Media
  • 440000Retail Trade
  • 449000Furniture, Home Furnishings, Electronics, and Appliance Retailers
  • 449200Electronics and Appliance Retailers
  • 449210Electronics and Appliance Retailers
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 334610Manufacturing and Reproducing Magnetic and Optical Media
  • 513210Software Publishers
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 5700Home Furniture, Furnishings, And Equipment Stores
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 5040Professional And Commercial Equipment And Supplies
  • 5730Radio, Television, Consumer Electronics, And Music Stores
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 5734Computer And Computer Software Stores
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 1820Reproduction of recorded media
  • 5820Software publishing